{"id":1004783,"date":"2026-09-21T09:04:08","date_gmt":"2026-09-21T13:04:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\/"},"modified":"2026-09-21T09:04:08","modified_gmt":"2026-09-21T13:04:08","slug":"palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\/","title":{"rendered":"Palisade Bio to Present at Stifel 2026 Virtual Immunology and Inflammation Forum"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\">\n        <i>Presentation scheduled for September 23, 2026 at 1:00 PM ET<\/i>\n      <\/p>\n<p align=\"center\">\n        <i>Access the webcast <\/i><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ENvCuraq1ZqzqSb3tPUyTfvsZQ7YCSzsyNbTsTs4Vw7mZowNxDprDttvIrN0QvI4VBG4KKScyAQwoDuQH60A6wNppd_d2D5Gz3Pt85TnMmlvhqyYitAJfxLvPerk-xE7OvwJd_VFEIdSvSy7n45Ih36GJcMtCxAm4ilebflc05OMKN1qsVUzileT6yEQxQH1_KqobELtKnVe4fI2Hh1V-rdxilB9yMAC7DNFgBp0xTNUmnjgkiH8QNmkfGVhkLow1yEIhzpwDV5qjZ8CQkOvRR_-U4_VmJKKz_HJFH2OUHGYNsw6ULDk-FZgpJVtMmrHE4yXH7fhu4zJTj5talTXRDr_lu4ixFwy5yFI0x4t4E0H886LxNAOgg26EwpMzgZZuwM5oI8LWnimsHIN-EpPqmbTEX7MngbnYGs_3BuWa9U=\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <i>here<\/i><br \/>\n        <\/a>\n      <\/p>\n<p align=\"justify\">\n        <b>Denver, CO, Sept.  21, 2026  (GLOBE NEWSWIRE) &#8212; <\/b>Palisade Bio, Inc. (Nasdaq: PALI) (\u201cPalisade\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company developing next-generation prodrugs for patients living with inflammatory and fibrotic diseases, today announced that JD Finley, Chief Executive Officer, and Mitchell Jones, M.D., Ph.D., President and Chief Medical Officer, will participate in the Stifel 2026 Virtual Immunology and Inflammation Forum.<\/p>\n<p align=\"justify\">\n        <b>Date: <\/b>September 23, 2026<br \/><b>Time:<\/b> 1:00 PM \u2013 1:25 PM ET<br \/><b>Presenters:<\/b> JD Finley, Chief Executive Officer; Mitchell Jones, President &amp; Chief Medical Officer<br \/><b>Format:<\/b> Virtual<\/p>\n<p align=\"justify\">The presentation will provide an update on the Company\u2019s PALI-2108 clinical development program, including recent progress across ulcerative colitis and Crohn\u2019s disease, the expanding clinical and translational data supporting PALI-2108\u2019s differentiated profile, and upcoming development milestones.<\/p>\n<p align=\"justify\">A live <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kik5t8MGVjBrAQF9JXo9Q1TMTurSP9hlfwYzc17QtBPgw5CZqvI6YxSdaagpdQgi9cgEQgJY5dhmH9LzdsvE9rUh_EkiJi9clPxBMEAcCHjYOYj56QMCWoureZaXDNfZFGK3K5jT_7F0z1khJ9z3UhhfhECKosAcgzMdhTmixowbAsQHeM5_7cDen_u1gsjlPUgwxGg4sezX9WHDiYt2kmYUwgXfYw7MSWCtaIAzlxTHGd8VJpgHaBd5Cm8DaFkdO9ZkEJxCBssfQX7-Pj1iCD1S9LOKPhgFxgHxROn6JMbHTzkgYgX30zjRT9k6C2LwanWieAR851jspmw3iGTjuTYu7mZF4DR2h0l8w0cAvdvgZvlzzQhoeICjrCCsIxwK_FAheGhCGdtcBU9lU83RRZnLK0oWCbMXBrI6bDzC15RPsETwOIRyyMegcF7ZjiUk\" rel=\"nofollow\" target=\"_blank\">webcast<\/a> of the presentation will be accessible on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mW23ikbgrPYnYu7nGmndkkjCW3NkQ654gQniQrYU4zV-wF8B_e17E-AMSG4_I7XqrRhvXe1aXfm6dS02a8REdVBo8nkrLxGxA2ybzMoeGXpbIsY-sfE2f7E14Vow30WT\" rel=\"nofollow\" target=\"_blank\">Events<\/a> page in the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AlZcKWQRLCsOw4cTsHkq2BIMIIJGmpPAl682ZQtdVFYSm9anpSXdj77ubV6xr71AxazAYSPB0oRJXBbOUCzL1A==\" rel=\"nofollow\" target=\"_blank\">Investors<\/a> section of the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=V2LiY4EUkc-SUXJZEHxcjhbHB8h1cLZgxSsJAU3_a3SITlutjC_FMERMrPPrQcxvLP73VYqGU6V3Om8a_GqzpA_RTAobDFW4dPN7NL1NKw0=\" rel=\"nofollow\" target=\"_blank\">palisadebio.com<\/a>. A replay will be available following the live event and will be archived for a limited time.<\/p>\n<p align=\"justify\">In addition to the presentation, management will be available to participate in one-on-one meetings with qualified members of the investor community who are registered for the conference.<\/p>\n<p align=\"justify\">\n        <b>About Palisade Bio<\/b>\n      <\/p>\n<p align=\"justify\">Palisade Bio, Inc. (Nasdaq: PALI) is a clinical-stage biopharmaceutical company developing prodrugs for patients living with inflammatory and fibrotic diseases.<\/p>\n<p align=\"justify\">For more information, please go to <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pD7aOfw7UhAnRkutFYCoSk6_ULwmBs1RJ1nd5qeDocTYMJ3oDZ5bgMcgOsqkJpp7fL6cVmOvdNkEDNH8NTYAEoOo4G7qgWuQD_kHSg9neWg=\" rel=\"nofollow\" target=\"_blank\">www.palisadebio.com<\/a>.<\/p>\n<p align=\"justify\">\n        <b>Investor Relations Contact<\/b>\n      <\/p>\n<p align=\"justify\">JTC Team, LLC<br \/>Jenene Thomas<br \/>908-824-0775<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PmKtJPAmZy72XbaMdEQQFqYujj19Qtj_gRzvhElDVkNrXAVHXjKF5Qeq2BMnbdVG0y62cJ9IZRIhlLP3xxNLGQ==\" rel=\"nofollow\" target=\"_blank\">PALI@jtcir.com<\/a>\u00a0<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyOTg5NyM3ODQyMjQ5IzUwMDEwOTEyMQ==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MjRlMTg0MTUtYmZiMy00NWJhLWE1ZDctYzQ0NjJmMWJmYzAyLTUwMDEwOTEyMS0yMDI2LTA5LTIxLWVu\/tiny\/Palisade-Bio-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Presentation scheduled for September 23, 2026 at 1:00 PM ET Access the webcast here Denver, CO, Sept. 21, 2026 (GLOBE NEWSWIRE) &#8212; Palisade Bio, Inc. (Nasdaq: PALI) (\u201cPalisade\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company developing next-generation prodrugs for patients living with inflammatory and fibrotic diseases, today announced that JD Finley, Chief Executive Officer, and Mitchell Jones, M.D., Ph.D., President and Chief Medical Officer, will participate in the Stifel 2026 Virtual Immunology and Inflammation Forum. Date: September 23, 2026Time: 1:00 PM \u2013 1:25 PM ETPresenters: JD Finley, Chief Executive Officer; Mitchell Jones, President &amp; Chief Medical OfficerFormat: Virtual The presentation will provide an update on the Company\u2019s PALI-2108 clinical development program, including recent progress across ulcerative colitis and Crohn\u2019s disease, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Palisade Bio to Present at Stifel 2026 Virtual Immunology and Inflammation Forum&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1004783","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Palisade Bio to Present at Stifel 2026 Virtual Immunology and Inflammation Forum - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Palisade Bio to Present at Stifel 2026 Virtual Immunology and Inflammation Forum - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Presentation scheduled for September 23, 2026 at 1:00 PM ET Access the webcast here Denver, CO, Sept. 21, 2026 (GLOBE NEWSWIRE) &#8212; Palisade Bio, Inc. (Nasdaq: PALI) (\u201cPalisade\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company developing next-generation prodrugs for patients living with inflammatory and fibrotic diseases, today announced that JD Finley, Chief Executive Officer, and Mitchell Jones, M.D., Ph.D., President and Chief Medical Officer, will participate in the Stifel 2026 Virtual Immunology and Inflammation Forum. Date: September 23, 2026Time: 1:00 PM \u2013 1:25 PM ETPresenters: JD Finley, Chief Executive Officer; Mitchell Jones, President &amp; Chief Medical OfficerFormat: Virtual The presentation will provide an update on the Company\u2019s PALI-2108 clinical development program, including recent progress across ulcerative colitis and Crohn\u2019s disease, &hellip; Continue reading &quot;Palisade Bio to Present at Stifel 2026 Virtual Immunology and Inflammation Forum&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-21T13:04:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyOTg5NyM3ODQyMjQ5IzUwMDEwOTEyMQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Palisade Bio to Present at Stifel 2026 Virtual Immunology and Inflammation Forum\",\"datePublished\":\"2026-09-21T13:04:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\\\/\"},\"wordCount\":255,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyOTg5NyM3ODQyMjQ5IzUwMDEwOTEyMQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\\\/\",\"name\":\"Palisade Bio to Present at Stifel 2026 Virtual Immunology and Inflammation Forum - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyOTg5NyM3ODQyMjQ5IzUwMDEwOTEyMQ==\",\"datePublished\":\"2026-09-21T13:04:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyOTg5NyM3ODQyMjQ5IzUwMDEwOTEyMQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyOTg5NyM3ODQyMjQ5IzUwMDEwOTEyMQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Palisade Bio to Present at Stifel 2026 Virtual Immunology and Inflammation Forum\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Palisade Bio to Present at Stifel 2026 Virtual Immunology and Inflammation Forum - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\/","og_locale":"en_US","og_type":"article","og_title":"Palisade Bio to Present at Stifel 2026 Virtual Immunology and Inflammation Forum - Market Newsdesk","og_description":"Presentation scheduled for September 23, 2026 at 1:00 PM ET Access the webcast here Denver, CO, Sept. 21, 2026 (GLOBE NEWSWIRE) &#8212; Palisade Bio, Inc. (Nasdaq: PALI) (\u201cPalisade\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company developing next-generation prodrugs for patients living with inflammatory and fibrotic diseases, today announced that JD Finley, Chief Executive Officer, and Mitchell Jones, M.D., Ph.D., President and Chief Medical Officer, will participate in the Stifel 2026 Virtual Immunology and Inflammation Forum. Date: September 23, 2026Time: 1:00 PM \u2013 1:25 PM ETPresenters: JD Finley, Chief Executive Officer; Mitchell Jones, President &amp; Chief Medical OfficerFormat: Virtual The presentation will provide an update on the Company\u2019s PALI-2108 clinical development program, including recent progress across ulcerative colitis and Crohn\u2019s disease, &hellip; Continue reading \"Palisade Bio to Present at Stifel 2026 Virtual Immunology and Inflammation Forum\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\/","og_site_name":"Market Newsdesk","article_published_time":"2026-09-21T13:04:08+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyOTg5NyM3ODQyMjQ5IzUwMDEwOTEyMQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Palisade Bio to Present at Stifel 2026 Virtual Immunology and Inflammation Forum","datePublished":"2026-09-21T13:04:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\/"},"wordCount":255,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyOTg5NyM3ODQyMjQ5IzUwMDEwOTEyMQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\/","name":"Palisade Bio to Present at Stifel 2026 Virtual Immunology and Inflammation Forum - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyOTg5NyM3ODQyMjQ5IzUwMDEwOTEyMQ==","datePublished":"2026-09-21T13:04:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyOTg5NyM3ODQyMjQ5IzUwMDEwOTEyMQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyOTg5NyM3ODQyMjQ5IzUwMDEwOTEyMQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/palisade-bio-to-present-at-stifel-2026-virtual-immunology-and-inflammation-forum\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Palisade Bio to Present at Stifel 2026 Virtual Immunology and Inflammation Forum"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1004783","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1004783"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1004783\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1004783"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1004783"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1004783"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}